Improving the diagnosis and treatment of the world's major
mental disorders.
The Mental Health Research Institute (MHRI) aims to be a global leader in research that improves the lives of people affected by mental illness
including psychotic illness (schizophrenia and depression) and neurodegenerative diseases
(dementia and Alzheimer’s disease).
Our objectives are:
To undertake sustainable, highest quality, basic neuroscience, clinical and public health research
To promote understanding of and investment in research through advocacy
To educate clinicians and researchers
To provide expert commentary on the scientific basis of mental illness including psychotic
illness (schizophrenia and depression) and neurodegenerative diseases (dementia and
Alzheimer’s disease).
Based in Melbourne, Australia, MHRI concentrates its efforts towards understanding:
Schizophrenia
Bipolar disorder
Major depression
Alzheimer's disease
Parkinson's disease
Huntington's disease
Mental Illness
Mental illnesses impose a significant burden on the health and well being of communities worldwide.
Five of the world's ten leading causes of disability are related to mental illness. The share of global disease burden associated with mental illnesses is predicted to grow further in the coming decades, increasing by almost 50%, from 10.5% of the total burden to almost 15% in 2020 (WHO, 2004).
Approximately 20% of all people will experience some form of mental illness un their lifetime.